Condition: Diabetic Foot Ulcer · Sponsor: Legacy Medical Consultants
The goal of this clinical trial is to learn if use of Orion™, a dual-layer amniotic membrane allograft, in addition to standard wound care treatment can improve patient outcomes for people over the age of 50 with diabetic foot ulcers. The study aims to determine the incidence of complete wound closure at the end of 12 weeks of treatment. Researchers will compare the outcomes between a group of people treated with standard wound care and another group treated with standard wound care in addition to the amniotic membrane allograft to see if the amniotic membrane allograft improves wound healing. During the study, participants will visit their doctor weekly over a 12 week period, which is standard for diabetic foot ulcer treatment procedures, and fill out a questionnaire measuring quality of life.
This description comes directly from the study's public registry record.
Cyaandi Dove, DPM · 210-567-5135 · dovec@ohsu.edu
Christopher Schultz, BS, CCRA, ACRP-PM · 719-400-7463 · cschultz@ecr-inc.com
Always discuss trial participation with your own doctor first.
| DPMG | Palm Springs, California, United States | Recruiting |
| Center for Clinical Research Inc. | San Francisco, California, United States | Recruiting |
| ILD Research Center | Vista, California, United States | Recruiting |
| Stamford Health Medical Group | Darien, Connecticut, United States | Recruiting |
| Optimum Care Research Center | Pembroke Pines, Florida, United States | Recruiting |
| Rosalind Franklin University of Medicine and Science | Chicago, Illinois, United States | Recruiting |
| Chesapeake Research Group | Pasadena, Maryland, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06420245